Clinical Trial Update: Sodium Valproate for GSDV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for sodium valproate in Glycogen Storage Disease Type V (McArdle Disease) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type
• Mcardle Disease

Drugs mentioned

• Sodium valproate (valproate)

Snippet

Sponsor: University College, London | Conditions: Glycogen Storage Disease Type V, McArdle Disease | Phase 2 | Status: COMPLETED